![Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer | Modern Pathology Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2010.55/MediaObjects/41379_2010_Article_BFmodpathol201055_Fig1_HTML.jpg)
Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer | Modern Pathology
![SciELO - Brasil - Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors Worse prognosis in breast cancer patients can SciELO - Brasil - Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors Worse prognosis in breast cancer patients can](https://minio.scielo.br/documentstore/1806-9282/QVZDg8pVmy9GPy3v5kPctrb/a9ba517f5f87e0202a157e93c57a4d0c9c06efde.jpg)
SciELO - Brasil - Worse prognosis in breast cancer patients can be predicted by immunohistochemical analysis of positive MMP-2 and negative estrogen and progesterone receptors Worse prognosis in breast cancer patients can
![Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine](https://www.mdpi.com/cancers/cancers-14-03469/article_deploy/html/images/cancers-14-03469-g006.png)
Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine
![Immunohistochemical comparison of different YB-1 antibodies in human... | Download Scientific Diagram Immunohistochemical comparison of different YB-1 antibodies in human... | Download Scientific Diagram](https://www.researchgate.net/publication/40024112/figure/fig3/AS:195398162489351@1423597960628/Immunohistochemical-comparison-of-different-YB-1-antibodies-in-human-invasive-breast.png)
Immunohistochemical comparison of different YB-1 antibodies in human... | Download Scientific Diagram
![Prediction and Prognosis of Biologically Aggressive Breast Cancers by the Combination of DWI/DCE-MRI and Immunohistochemical Tumor Markers - Atiya Allarakha - Discovery Medicine Prediction and Prognosis of Biologically Aggressive Breast Cancers by the Combination of DWI/DCE-MRI and Immunohistochemical Tumor Markers - Atiya Allarakha - Discovery Medicine](https://www.discoverymedicine.com/Atiya-Allarakha/files/2019/01/discovery_medicine_no_146_pei_jun_wang_figure_1.jpg)
Prediction and Prognosis of Biologically Aggressive Breast Cancers by the Combination of DWI/DCE-MRI and Immunohistochemical Tumor Markers - Atiya Allarakha - Discovery Medicine
![Table 1 from Immunohistochemical characteristics of Breast Cancer patients with the comparative study of BRCA1, ER, PR, BCL2, P53 and Ki-67 immunohistochemical markers: A population based study. | Semantic Scholar Table 1 from Immunohistochemical characteristics of Breast Cancer patients with the comparative study of BRCA1, ER, PR, BCL2, P53 and Ki-67 immunohistochemical markers: A population based study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3fef50f667e7a94d557b63ba6d277af23a5057dc/3-Table1-1.png)
Table 1 from Immunohistochemical characteristics of Breast Cancer patients with the comparative study of BRCA1, ER, PR, BCL2, P53 and Ki-67 immunohistochemical markers: A population based study. | Semantic Scholar
![PDF] Title : Use of Immunohistochemical Markers can Refine Prognosis in Triple Negative Breast Cancer | Semantic Scholar PDF] Title : Use of Immunohistochemical Markers can Refine Prognosis in Triple Negative Breast Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ee0e4354765e467958dae5f11f53974766b53b84/19-Table1-1.png)
PDF] Title : Use of Immunohistochemical Markers can Refine Prognosis in Triple Negative Breast Cancer | Semantic Scholar
![Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67? - The Lancet Oncology Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67? - The Lancet Oncology](https://www.thelancet.com/cms/asset/ed12412f-1b6d-43e6-87a0-6b737c3725fa/gr1.jpg)
Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67? - The Lancet Oncology
![P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice | Modern Pathology P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2016.232/MediaObjects/41379_2017_Article_BFmodpathol2016232_Fig1_HTML.jpg)
P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice | Modern Pathology
![Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419477612-gr1.jpg)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? - ScienceDirect
![Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence - Tien - 2021 - Histopathology - Wiley Online Library Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence - Tien - 2021 - Histopathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/655964d5-7b05-47d6-9e05-6230c8327d49/his14328-toc-0001-m.png)
Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence - Tien - 2021 - Histopathology - Wiley Online Library
![Classification of breast cancer subtypes according to IHC marker profile. | Download Scientific Diagram Classification of breast cancer subtypes according to IHC marker profile. | Download Scientific Diagram](https://www.researchgate.net/profile/Jelle-Wesseling/publication/44646923/figure/fig4/AS:341276873510913@1458378155028/Classification-of-breast-cancer-subtypes-according-to-IHC-marker-profile_Q640.jpg)
Classification of breast cancer subtypes according to IHC marker profile. | Download Scientific Diagram
![Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine](https://www.mdpi.com/cancers/cancers-14-03469/article_deploy/html/images/cancers-14-03469-g001.png)
Cancers | Free Full-Text | From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine
![Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352304220301628-gr1.jpg)
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
![Medicina | Free Full-Text | Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities Medicina | Free Full-Text | Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities](https://www.mdpi.com/medicina/medicina-57-00062/article_deploy/html/images/medicina-57-00062-g001.png)
Medicina | Free Full-Text | Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
![Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1092913420301805-ga1.jpg)
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies | PLOS Medicine
![Surrogate molecular classification of breast carcinoma: A classification in need or a dilemma indeed Dewan K, Mandal AK - Oncol J India Surrogate molecular classification of breast carcinoma: A classification in need or a dilemma indeed Dewan K, Mandal AK - Oncol J India](https://www.ojionline.org/articles/2020/4/3/images/OncolJIndia_2020_4_3_79_301588_f1.jpg)